Details

Autor(en) / Beteiligte

• Wei, Wenjin
• Xu, Xiupeng
• Li, Hailin
• Zhang, Yaxuan
• Han, Dongfeng
• Wang, Yingyi
• Yan, Wei
• Wang, Xiefeng
• Zhang, Junxia
• Liu, Ning
• You, Yongping

Titel

The SIRT2 Polymorphism rs10410544 and Risk of Alzheimer’s Disease: A Meta-analysis

Ist Teil von

• Neuromolecular medicine, 2014-06, Vol.16 (2), p.448-456

Ort / Verlag

Boston: Springer US

Erscheinungsjahr

2014

Quelle

MEDLINE

Beschreibungen/Notizen

• Previous studies have reported an association between human sirtuins’ single-nucleotide polymorphisms (SNPs) and Alzheimer’s disease (AD) susceptibility in the apolipoprotein E (APOE) ε4-negative population, although the findings are inconsistent. To obtain a more precise estimation of this relationship, we conducted a meta-analysis to assess the association between the rs10410544 C/T polymorphism of SIRT2 and the risk of AD with APOE ε4 status. We searched all relevant PubMed publications and included three studies in our meta-analysis involving a total of 1,794 patients and 2,054 control subjects. Odds ratios (ORs) with 95 % confidence intervals (CIs) were employed to evaluate the association of the SIRT2 SNP with AD susceptibility, and we analyzed the extracted data stratified by the APOE ε4-carrying status. Overall, the results show that the SIRT2 SNP is associated with human AD risk in the comparison models (T vs. C: OR 1.140, 95 % CI 1.034–1.258; TC vs. CC: OR 1.178, 95 % CI 1.019–1.361; TT + TC vs. CC: OR 1.197, 95 % CI 1.043–1.373). In the stratified analyses, the European population had a significantly increased risk of AD (T vs. C: OR 1.110, 95 % CI 1.002–1.229), and we also observed a significant association in the APOE ε4-negative population (T vs. C: OR 1.165, 95 % CI 1.025–1.324; TT + TC vs. CC: OR 1.222, 95 % CI 1.022–1.461). This meta-analysis indicates that the presence of the SIRT2 SNP with APOE ε4-negative status contributes to the development of AD in humans Epidemiological studies of larger sample sizes are warranted to confirm this hypothesis.